Non-dermatophytic onychomycosis. An understimated entity? A study of 51 cases.
The aim of our study was to evaluate the incidence, the clinic characteristics, the therapeutic antifungal response and the evaluation of side-effects in 51 non-dermatophytic onychomycosis cases which were observed in a case-study of 1012 patients, affected by different types of onychopathy, attending the Mycology Ambulatory of San Paolo Hospital, Milan, Italy during the period 1994-97.
Gianni
C
C
Università degli Studi di Milano, Clinica Dermatologica IV, Ospedale San Paolo, Italy.
Cerri
A
A
Crosti
C
C
D000935:Antifungal Agents / Q000627:therapeutic use; D005533:Foot Dermatoses / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D006229:Hand Dermatoses / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D009281:Naphthalenes / Q000627:therapeutic use; D014009:Onychomycosis / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D000077291:Terbinafine
D000935:Antifungal Agents; D009281:Naphthalenes; D017964:Itraconazole; D000077291:Terbinafine